BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 25394146)

  • 1. Plasmacytoid Dendritic cells (pDCs) in HIV-infected and HIV/HCV-co-infected patients receiving successful treatment.
    Khokhlova O; Reizis A; Serebrovskaya L; Gerasimova N; Pokrovskiy V
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19642. PubMed ID: 25394146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host Genetic Factors and Dendritic Cell Responses Associated with the Outcome of Interferon/Ribavirin Treatment in HIV-1/HCV Co-Infected Individuals.
    Sehgal M; Zeremski M; Talal AH; Khan ZK; Capocasale R; Philip R; Jain P
    J Clin Cell Immunol; 2014 Oct; 5():. PubMed ID: 25705565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus alternate reading frame protein decreases interferon-α secretion in peripheral blood mononuclear cells.
    Xu X; Yu X; Deng X; Yue M; Zhang J; Zhu D; Zhou Z; Zhai X; Xu K; Zhang Y
    Mol Med Rep; 2014 Feb; 9(2):730-6. PubMed ID: 24270940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
    Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early plasmacytoid dendritic cell changes predict plasma HIV load rebound during primary infection.
    Pacanowski J; Develioglu L; Kamga I; Sinet M; Desvarieux M; Girard PM; Hosmalin A
    J Infect Dis; 2004 Nov; 190(10):1889-92. PubMed ID: 15499547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmacytoid dendritic cells (pDCs) from HIV controllers produce interferon-α and differentiate into functional killer pDCs under HIV activation.
    Barblu L; Machmach K; Gras C; Delfraissy JF; Boufassa F; Leal M; Ruiz-Mateos E; Lambotte O; Herbeuval JP;
    J Infect Dis; 2012 Sep; 206(5):790-801. PubMed ID: 22693234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrahepatic mRNA expression in hepatitis C virus and HIV/hepatitis C virus co-infection: infiltrating cells, cytokines, and influence of HAART.
    Kuntzen T; Tural C; Li B; Feldmann G; Kupfer B; Nischalke HD; Clotet B; Sauerbruch T; Rockstroh JK; Spengler U
    AIDS; 2008 Jan; 22(2):203-10. PubMed ID: 18097222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study on the function of circulating plasmacytoid dendritic cells in the immunoactive phase of patients with chronic genotype B and C HBV infection.
    Wang K; Fan X; Fan Y; Wang B; Han L; Hou Y
    J Viral Hepat; 2007 Apr; 14(4):276-82. PubMed ID: 17381720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of type I interferon-associated viral sensing during acute simian immunodeficiency virus infection in African green monkeys.
    Jochems SP; Petitjean G; Kunkel D; Liovat AS; Ploquin MJ; Barré-Sinoussi F; Lebon P; Jacquelin B; Müller-Trutwin MC
    J Virol; 2015 Jan; 89(1):751-62. PubMed ID: 25355871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between peripheral blood dendritic cells and cytokines involved in the pathogenesis of systemic lupus erythematosus.
    Robak E; Smolewski P; Wozniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
    Eur Cytokine Netw; 2004; 15(3):222-30. PubMed ID: 15542447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irreversible loss of pDCs by apoptosis during early HIV infection may be a critical determinant of immune dysfunction.
    Meera S; Madhuri T; Manisha G; Ramesh P
    Viral Immunol; 2010 Jun; 23(3):241-9. PubMed ID: 20565289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Interleukin-29 on Interferon-α Secretion by Peripheral Blood Mononuclear Cells.
    Cho CH; Yoon SY; Lee CK; Lim CS; Cho Y
    Cell J; 2015; 16(4):528-37. PubMed ID: 25685743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type I interferon production is profoundly and transiently impaired in primary HIV-1 infection.
    Kamga I; Kahi S; Develioglu L; Lichtner M; Marañón C; Deveau C; Meyer L; Goujard C; Lebon P; Sinet M; Hosmalin A
    J Infect Dis; 2005 Jul; 192(2):303-10. PubMed ID: 15962225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similar changes in plasmacytoid dendritic cell and CD4 T-cell counts during primary HIV-1 infection and treatment.
    Killian MS; Fujimura SH; Hecht FM; Levy JA
    AIDS; 2006 Jun; 20(9):1247-52. PubMed ID: 16816552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of HIV on cell survival and antiviral activity of plasmacytoid dendritic cells.
    Meyers JH; Justement JS; Hallahan CW; Blair ET; Sun YA; O'Shea MA; Roby G; Kottilil S; Moir S; Kovacs CM; Chun TW; Fauci AS
    PLoS One; 2007 May; 2(5):e458. PubMed ID: 17520017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification and functional analysis of plasmacytoid dendritic cells in patients with chronic hepatitis C virus infection.
    Goutagny N; Vieux C; Decullier E; Ligeoix B; Epstein A; Trepo C; Couzigou P; Inchauspe G; Bain C
    J Infect Dis; 2004 May; 189(9):1646-55. PubMed ID: 15116301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal analysis of distribution and function of plasmacytoid dendritic cells in peripheral blood and gut mucosa of HIV infected patients.
    Lehmann C; Jung N; Förster K; Koch N; Leifeld L; Fischer J; Mauss S; Drebber U; Steffen HM; Romerio F; Fätkenheuer G; Hartmann P
    J Infect Dis; 2014 Mar; 209(6):940-9. PubMed ID: 24259523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of baseline CD4(+) T cell counts on the efficacy of nevirapine-based highly active antiretroviral therapy in Chinese HIV/AIDS patients: a prospective, multicentric study.
    Liu ZY; Guo FP; Han Y; Qiu ZF; Zuo LY; Li YL; Li TS
    Chin Med J (Engl); 2009 Oct; 122(20):2497-502. PubMed ID: 20079166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of control selection on sustained viral response rates in genotype 2/3 HCV mono-infected versus HIV/HCV co-infected patients.
    Nilsson J; Weiland O
    Scand J Infect Dis; 2010 Jul; 42(6-7):533-9. PubMed ID: 20214543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.